Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

well stated. prev board discussion about early results release phase 1, with Memorial Sloan Kettering and Agios, with striking results of efficacy in a phase 1 trial

Of course agreed there are not many stage 4 thymoma pts in the world
Agreed(with sun spotter) that cherry picking from phase 1 is an iffy business. Agreed that CTIX was backed into a corner and wanted to say something that might not have been released at all otherwise.

But it remains intriguing nonetheless, and the question is an open one, who will benefit from K at more frequent dosing?

This is a billion dollar question, of interest for all shareholders, but more important is the issue of improving survival in cancer patients. Those of us who do not die of cardiovascular disease(MI/CHF/stroke) are likely to get some type of cancer sometime down the road.